Skip to main content
. 2017 Aug 24;12(8):e0183263. doi: 10.1371/journal.pone.0183263

Fig 7. Disruption of A. baumannii biofilms.

Fig 7

(A) Absorbance of crystal violet staining of the A. baumannii biofilms grown on glass cover slips in presence of colistin (30 μg mL-1), Qn-prAP and QCybuAP (both at 30 μg mL-1), erythromycin (Ery, 30 μg mL-1), tobramycin (Tobra, 30 μg mL-1), erythromycin + Qn-prAP/QCybuAP (30 μg mL-1 + 30 μg mL-1); (B) Reduction in bacterial cell counts in biofilms with the treatment of colistin (50 μg mL-1), Qn-prAP and QCybuAP (both at 50 μg mL-1), erythromycin (Ery, 50 μg mL-1), tobramycin (Tobra, 50 μg mL-1), erythromycin + Qn-prAP/QCybuAP (50 μg mL-1 + 50 μg mL-1) compared to untreated control. (limit of detection < 50 CFU/mL).